NCT05817214 2024-04-19Cadonilimab Plus Anlotinib for R/M/P Cervical CancerZhongnan HospitalPhase 2 Recruiting35 enrolled
NCT05137171 2021-11-30AK105 Combined With Anlotinib in Patients With Cervical CancerThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Unknown36 enrolled